KR950700903A - 5-ht1 작용물질로서의 아실아미노인돌 유도체(acylaminoindole derivatives as 5-ht1 agonists) - Google Patents

5-ht1 작용물질로서의 아실아미노인돌 유도체(acylaminoindole derivatives as 5-ht1 agonists)

Info

Publication number
KR950700903A
KR950700903A KR1019940703551A KR19940703551A KR950700903A KR 950700903 A KR950700903 A KR 950700903A KR 1019940703551 A KR1019940703551 A KR 1019940703551A KR 19940703551 A KR19940703551 A KR 19940703551A KR 950700903 A KR950700903 A KR 950700903A
Authority
KR
South Korea
Prior art keywords
aryl
alkyl
alkylaryl
hydrogen
pct
Prior art date
Application number
KR1019940703551A
Other languages
English (en)
Other versions
KR0179074B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700903A publication Critical patent/KR950700903A/ko
Application granted granted Critical
Publication of KR0179074B1 publication Critical patent/KR0179074B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Soft Magnetic Materials (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Pyrrole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1019940703551A 1992-04-10 1993-03-04 5-ht1 작용물질로서의 아실아미노인돌 유도체 KR0179074B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86638292A 1992-04-10 1992-04-10
US7/866382 1992-04-10
PCT/US1993/001807 WO1993021180A1 (en) 1992-04-10 1993-03-04 Acylaminoindole derivatives as 5-ht1 agonists

Publications (2)

Publication Number Publication Date
KR950700903A true KR950700903A (ko) 1995-02-20
KR0179074B1 KR0179074B1 (ko) 1999-03-20

Family

ID=25347493

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940703551A KR0179074B1 (ko) 1992-04-10 1993-03-04 5-ht1 작용물질로서의 아실아미노인돌 유도체

Country Status (31)

Country Link
US (1) US5498626A (ko)
EP (1) EP0635015B1 (ko)
JP (1) JP2544704B2 (ko)
KR (1) KR0179074B1 (ko)
CN (1) CN1038506C (ko)
AT (1) ATE148465T1 (ko)
AU (1) AU670270B2 (ko)
BR (1) BR9306221A (ko)
CA (1) CA2132706C (ko)
CZ (1) CZ282653B6 (ko)
DE (1) DE69307875T2 (ko)
DK (1) DK0635015T3 (ko)
EG (1) EG20466A (ko)
ES (1) ES2097496T3 (ko)
FI (2) FI111256B (ko)
GR (1) GR3022767T3 (ko)
HR (1) HRP930753B1 (ko)
HU (1) HUT64060A (ko)
IL (1) IL105309A0 (ko)
MX (1) MX9301996A (ko)
MY (1) MY115278A (ko)
NO (1) NO309860B1 (ko)
NZ (1) NZ251047A (ko)
PL (1) PL172232B1 (ko)
RU (1) RU2110516C1 (ko)
SK (1) SK278182B6 (ko)
TW (1) TW394769B (ko)
UA (1) UA34452C2 (ko)
WO (1) WO1993021180A1 (ko)
YU (1) YU48916B (ko)
ZA (1) ZA932536B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
BR9306201A (pt) 1992-04-07 1998-06-23 Pfizer Derivados de indol como agonistas 5-ht1
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
EP0716649B1 (en) * 1993-08-31 1998-09-09 Pfizer Inc. 5-arylindole derivatives
GB9402011D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
AU3162695A (en) * 1994-08-03 1996-03-04 Asta Medica Aktiengesellschaft Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
AU3170099A (en) * 1998-04-16 1999-11-08 Yamanouchi Pharmaceutical Co., Ltd. Remedies for obesity
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
CA2514024A1 (en) * 2003-01-22 2004-08-05 Gtx Inc. Treating androgen deficiency in female (adif)-associated conditions with sarms
WO2009071988A1 (en) * 2007-12-07 2009-06-11 Pfizer Inc. Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
NL8103764A (nl) * 1980-08-12 1982-03-01 Glaxo Group Ltd Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
UA41297C2 (uk) * 1991-11-25 2001-09-17 Пфайзер, Інк. Похідні індолу, фармацевтична композиція і спосіб лікування

Also Published As

Publication number Publication date
NO943803D0 (no) 1994-10-07
YU48916B (sh) 2002-11-15
EP0635015B1 (en) 1997-01-29
HRP930753A2 (en) 1994-10-31
IL105309A0 (en) 1993-08-18
FI931613A (fi) 1993-10-11
TW394769B (en) 2000-06-21
DE69307875D1 (de) 1997-03-13
JP2544704B2 (ja) 1996-10-16
MX9301996A (es) 1994-03-31
HRP930753B1 (en) 2000-10-31
NO943803L (no) 1994-10-07
ZA932536B (en) 1994-10-08
AU3782193A (en) 1993-11-18
RU2110516C1 (ru) 1998-05-10
JPH07501831A (ja) 1995-02-23
CZ282653B6 (cs) 1997-08-13
DK0635015T3 (da) 1997-03-17
RU94045902A (ru) 1996-08-27
ES2097496T3 (es) 1997-04-01
UA34452C2 (uk) 2001-03-15
CA2132706A1 (en) 1993-10-28
EG20466A (en) 1999-05-31
MY115278A (en) 2003-05-31
NO309860B1 (no) 2001-04-09
GR3022767T3 (en) 1997-06-30
FI111256B (fi) 2003-06-30
CZ247794A3 (en) 1995-07-12
FI931613A0 (fi) 1993-04-08
SK120794A3 (en) 1995-05-10
EP0635015A1 (en) 1995-01-25
CN1080288A (zh) 1994-01-05
US5498626A (en) 1996-03-12
CN1038506C (zh) 1998-05-27
AU670270B2 (en) 1996-07-11
ATE148465T1 (de) 1997-02-15
HUT64060A (en) 1993-11-29
FI20010214A (fi) 2001-02-05
PL172232B1 (pl) 1997-08-29
DE69307875T2 (de) 1997-05-22
YU25593A (sh) 1996-10-09
HU9301048D0 (en) 1993-06-28
BR9306221A (pt) 1998-06-30
WO1993021180A1 (en) 1993-10-28
CA2132706C (en) 1998-08-04
SK278182B6 (en) 1996-03-06
NZ251047A (en) 1996-09-25
KR0179074B1 (ko) 1999-03-20

Similar Documents

Publication Publication Date Title
KR950700903A (ko) 5-ht1 작용물질로서의 아실아미노인돌 유도체(acylaminoindole derivatives as 5-ht1 agonists)
FI942395A0 (fi) Indolijohdannaiset
MY108909A (en) Indole derivatives
MY111683A (en) Indole derivatives.
KR960704843A (ko) 5-아릴인돌 유도체 (5-arylindole derivatives)
CA2117643A1 (en) Indole Derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E801 Decision on dismissal of amendment
J121 Written withdrawal of request for trial
E601 Decision to refuse application
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20021029

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee